Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
G
Greenyn Biotechnology Co Ltd
TPEX:6846
Greenyn Biotechnology Co Ltd
TPEX:6846
Price:
58.3
TWD
1.04%
Market Closed
Market Cap:
NT$1.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
G
|
Greenyn Biotechnology Co Ltd
TPEX:6846
|
TW |
|
I
|
Immutep Ltd
NASDAQ:IMMP
|
AU |
|
Aboitiz Equity Ventures Inc
OTC:ABOIF
|
PH |
|
O
|
Oriole Resources PLC
F:S1Y
|
UK |
|
M
|
Microsoft Corp
SWB:MSF
|
US |
|
I
|
Integrated System Credit Consulting Fintech SpA
F:L7H
|
IT |
|
A
|
Advance ZincTek Ltd
F:BBJ
|
AU |
|
D
|
Dometic Group AB (publ)
F:D00
|
SE |
|
Cynata Therapeutics Ltd
F:51S
|
AU |
|
Ashland Global Holdings Inc
NYSE:ASH
|
US |
|
F
|
Firan Technology Group Corp
F:22F
|
CA |
|
C
|
Cellev8 Nutrition Inc
OTC:CELV
|
CA |
|
A
|
Asahi Intecc Co Ltd
F:6XT
|
JP |
|
I
|
Ingenia Communities Group
OTC:INGEF
|
AU |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Greenyn Biotechnology Co Ltd's stock price target?
Not Available
Greenyn Biotechnology Co Ltd does not have any price targets made by Wall Street professionals.
What is the Gross Profit forecast for Greenyn Biotechnology Co Ltd?
Projected CAGR
9%
9%
Over the last 5 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next -1 years is 9%.
What is the Pre-Tax Income forecast for Greenyn Biotechnology Co Ltd?
Projected CAGR
4%
4%
Over the last 5 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next -1 years is 4%.
What is the Net Income forecast for Greenyn Biotechnology Co Ltd?
Projected CAGR
4%
4%
Over the last 5 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next -1 years is 4%.